(Q73033933)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9018092%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Clinical evaluation of potential usefulness of CEA, CA 15-3, and MCA in follow-up of breast cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9018092%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

B Jezersek

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9018092%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J Cervek

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9018092%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Z Rudolf

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9018092%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

S Novaković

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9018092%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 December 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9018092%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9018092%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9018092%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9018092%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

137-144

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9018092%20AND%20SRC:MED&resulttype=core&format=json

CA-15.3, TPA and MCA as markers for breast cancer

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904473-4

7 January 2021

Clinical Applications of Serum Tumor Markers

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904473-4

7 January 2021

Preliminary Study on Serum Levels of Mucinous like Cancer Antigen (MCA) in Patients with Breast Disease: Comparison with CEA

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904473-4

7 January 2021

Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904473-4

7 January 2021

The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904473-4

7 January 2021

The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904473-4

7 January 2021

DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904473-4

7 January 2021

CEA (carcinoembryonic antigen): Its role as a marker in the management of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904473-4

7 January 2021

Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904473-4

7 January 2021

Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904473-4

7 January 2021

Use of mucin like cancer associated antigen (MCA) in the management of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904473-4

7 January 2021

Clinical value of a mucin-like carcinoma-associated antigen in monitoring breast cancer patients in comparison with CA 15-3

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904473-4

7 January 2021

Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904473-4

7 January 2021

Localization of mucinous-like carcinoma associated antigen (MCA) in breast pathology: comparison with carcinoembryonic antigen (CEA) and tissue polypeptide antigen (TPA)

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904473-4

7 January 2021

Comparison of CA 15-3 and CEA in diagnosis and monitoring of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904473-4

7 January 2021

Monoclonal antibodies against antigens on breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904473-4

7 January 2021

Clinical correlation between CEA and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904473-4

7 January 2021

CA 15.3, CEA and TPA tumor markers in the early diagnosis of breast cancer relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904473-4

7 January 2021

Serum c-erbB-2 in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904473-4

7 January 2021

The immunohistochemical reactivity of a new anti-epithelial monoclonal antibody (MAb b-12) against breast carcinoma and other normal and neoplastic human tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904473-4

7 January 2021

10.1016/S0304-3835(96)04473-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9018092%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference